# Factorial Energy Inc.: financial statements, quarterly

FAC · Nasdaq · CIK 2049662 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fac.md) · [Financials](/companies/fac/financials.md) · [Filings](/companies/fac/filings.md) · [Insiders](/companies/fac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fac/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | not reported | [6.7](/filings/0001628280-26-055707.md) | not reported | not reported | not reported | [6.6](/filings/0001628280-26-055707.md) |
| Selling, general and administrative | $m | not reported | [4.7](/filings/0001628280-26-055707.md) | not reported | not reported | not reported | [6.4](/filings/0001628280-26-055707.md) |
| Operating income | $m | [(0.0)](/filings/0001104659-26-062778.md) | [(11.4)](/filings/0001628280-26-055707.md) | [(0.1)](/filings/0001104659-25-112445.md) | [(0.6) d](/filings/0001104659-26-032882.md) | [(0.8)](/filings/0001104659-26-062778.md) | [(13.0)](/filings/0001628280-26-055707.md) |
| Income tax | $m | [0.0](/filings/0001410578-25-001417.md) | [0.0](/filings/0001628280-26-055707.md) | [0.0 d](/filings/0001104659-25-112445.md) | [0.0 d](/filings/0001104659-26-062778.md) | [0.0](/filings/0001104659-26-062778.md) | [0.0](/filings/0001628280-26-055707.md) |
| Net income | $m | [(12.9)](/filings/0001628280-26-055707.md) | [(10.6)](/filings/0001628280-26-055707.md) | [2.8](/filings/0001104659-25-112445.md) | [2.2 d](/filings/0001104659-26-032882.md) | [(8.6)](/filings/0001628280-26-055707.md) | [(11.3)](/filings/0001628280-26-055707.md) |
| Diluted EPS | $ per share | not reported | [(0.57)](/filings/0001628280-26-055707.md) | not reported | not reported | not reported | [(0.85)](/filings/0001628280-26-055707.md) |
| Basic EPS | $ per share | not reported | [(0.57)](/filings/0001628280-26-055707.md) | not reported | not reported | not reported | [(0.61)](/filings/0001628280-26-055707.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-10-31) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001104659-26-032882.md) | [0.0](/filings/0001104659-26-032882.md) | [0.0](/filings/0001410578-25-001417.md) | [34.5](/filings/0001628280-26-055707.md) | [0.0](/filings/0001104659-25-112445.md) | [28.9](/filings/0001628280-26-055707.md) | [0.0](/filings/0001104659-26-062778.md) | [113](/filings/0001628280-26-055707.md) |
| Current assets | $m | not reported | [0.0](/filings/0001104659-26-032882.md) | not reported | [1.0](/filings/0001410578-25-001828.md) | [0.8](/filings/0001104659-25-112445.md) | [32.9](/filings/0001628280-26-055707.md) | [0.5](/filings/0001104659-26-062778.md) | [116](/filings/0001628280-26-055707.md) |
| Total assets | $m | not reported | [0.3](/filings/0001104659-26-032882.md) | [0.7](/filings/0001410578-25-001417.md) | [279](/filings/0001410578-25-001828.md) | [282](/filings/0001104659-25-112445.md) | [62.8](/filings/0001628280-26-055707.md) | [286](/filings/0001104659-26-062778.md) | [143](/filings/0001628280-26-055707.md) |
| Current liabilities | $m | not reported | [0.3](/filings/0001104659-26-032882.md) | [0.7](/filings/0001410578-25-001417.md) | [0.4](/filings/0001410578-25-001828.md) | [0.4](/filings/0001104659-25-112445.md) | [5.1](/filings/0001628280-26-055707.md) | [1.4](/filings/0001104659-26-062778.md) | [6.6](/filings/0001628280-26-055707.md) |
| Total liabilities | $m | not reported | [0.3](/filings/0001104659-26-032882.md) | not reported | [13.6](/filings/0001410578-25-001828.md) | [13.5](/filings/0001104659-25-112445.md) | [34.5](/filings/0001628280-26-055707.md) | [14.5](/filings/0001104659-26-062778.md) | [57.7](/filings/0001628280-26-055707.md) |
| Shareholders' equity | $m | [0.0](/filings/0001104659-26-032882.md) | [(156)](/filings/0001628280-26-055707.md) | [(165)](/filings/0001628280-26-055707.md) | [(174)](/filings/0001628280-26-055707.md) | [(12.6)](/filings/0001104659-25-112445.md) | [(221)](/filings/0001628280-26-055707.md) | [(229)](/filings/0001628280-26-055707.md) | [85.0](/filings/0001628280-26-055707.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.6 d](/filings/0001104659-25-112445.md) | [(0.0) d](/filings/0001104659-26-032882.md) | [(0.2)](/filings/0001104659-26-062778.md) | [(11.2) d](/filings/0001628280-26-055707.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q2 FY2025 (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.4](/filings/0001628280-26-055707.md) | [18.9](/filings/0001628280-26-055707.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.